Literature DB >> 18160197

Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?

Masae Mitoma1, Reiji Yoshimura, Atsuko Sugita, Wakako Umene, Hikaru Hori, Hideki Nakano, Nobuhisa Ueda, Jun Nakamura.   

Abstract

There is growing evidence that blood levels of brain-derived neurotrophic factor (BDNF) and catecholamine, and cytokines are related to not only to depressive, suicidal, and anxious states but also to depression-associated personality traits. Psychological job stress is well known to lead to symptoms of depression and anxiety. In the present study, we examined effects of psychological job stress on serum levels of BDNF and plasma levels of catecholamine metabolites, and cytokines in healthy volunteers (n=106, male/female=42/64, age=36+/-12 yr) working in a hospital setting. The values (mean+/-SD) of scores for stress items in the Stress and Arousal Check List (s-SACL), plasma MHPG levels, and, serum BDNF levels in all participants were 7.2+/-3.3, 5.2+/-3.4 ng/mL, and 23.3+/-14.7 ng/mL, respectively. A negative correlation was found between scores for s-SACL and serum BDNF levels (rho=-0.211, p=0.022). A positive correlation was also found between scores on the s-SACL and plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) (rho=0.416, p=0.01), but not homovanillic acid (HVA). No relationship was found between s-SACL scores and plasma levels of interleukin-6 (IL-6) or tumor necrosis factor alpha (TNFalpha). These results suggest that serum BDNF levels and plasma MHPG levels might be biological markers reflective of psychological job stress in hospital employees.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160197     DOI: 10.1016/j.pnpbp.2007.11.011

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  25 in total

Review 1.  BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity.

Authors:  J J Rakofsky; K J Ressler; B W Dunlop
Journal:  Mol Psychiatry       Date:  2011-09-20       Impact factor: 15.992

2.  A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques.

Authors:  Francesca Cirulli; Andreas Reif; Sabine Herterich; K Peter Lesch; Alessandra Berry; Nadia Francia; Luigi Aloe; Christina S Barr; Stephen J Suomi; Enrico Alleva
Journal:  Psychoneuroendocrinology       Date:  2010-12-09       Impact factor: 4.905

3.  Serum BDNF levels before treatment predict SSRI response in depression.

Authors:  Owen M Wolkowitz; Jessica Wolf; Wendy Shelly; Rebecca Rosser; Heather M Burke; George K Lerner; Victor I Reus; J Craig Nelson; Elissa S Epel; Synthia H Mellon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-07-03       Impact factor: 5.067

Review 4.  [The development of depression: the role of brain-derived neurotrophic factor].

Authors:  H Stuke; R Hellweg; F Bermpohl
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

5.  Brain-derived neurotrophic factor in human saliva: ELISA optimization and biological correlates.

Authors:  Abigail L Mandel; Hakan Ozdener; Virginia Utermohlen
Journal:  J Immunoassay Immunochem       Date:  2011

6.  BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects.

Authors:  Alessandra Minelli; Roberta Zanardini; Cristian Bonvicini; Riccardo Sartori; Laura Pedrini; Massimo Gennarelli; Luisella Bocchio-Chiavetto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-03       Impact factor: 5.270

7.  A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites.

Authors:  Li Xie; Liqin Chen; Pan Gu; Lanlan Wei; Xuejun Kang
Journal:  J Vis Exp       Date:  2018-03-01       Impact factor: 1.355

8.  Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.

Authors:  Srijan Sen; Ronald Duman; Gerard Sanacora
Journal:  Biol Psychiatry       Date:  2008-06-24       Impact factor: 13.382

9.  Developing biomarkers for methamphetamine addiction.

Authors:  John Mendelson; Matthew J Baggott; Keith Flower; Gantt Galloway
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

10.  Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses.

Authors:  Marie-Claude Audet; Hymie Anisman
Journal:  Front Cell Neurosci       Date:  2013-05-10       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.